Showing results (391-400 of 663) with videos related to

Sort By:
Pageof 67
Rheumatology (Oxford, England)|September 23, 2021
Long-term efficacy and safety of canakinumab in patients with mevalonate kinase deficiency: results from the randomised Phase 3 CLUSTER trialJerold Jeyaratnam, Anna Simon, Inmaculada Calvo, et al.
Annals of the Rheumatic Diseases|September 13, 2013
Validation of the auto-inflammatory diseases activity index (AIDAI) for hereditary recurrent fever syndromesMaryam Piram, Isabelle Koné-Paut, Helen J Lachmann, et al.
Translational Andrology and Urology|June 18, 2025
Improving outcomes in robot-assisted urologic oncology surgery using a perioperative electronic health programAlae Touzani, Nam-Son Vuong, Alessandro Uleri, et al.
Arthritis and Rheumatism|March 3, 2007
The Pediatric Rheumatology European Society/American College of Rheumatology/European League against Rheumatism provisional classification criteria for juvenile systemic sclerosisFrancesco Zulian, Patricia Woo, Balu H Athreya, et al.
Arthritis Care & Research|April 26, 2018
American College of Rheumatology Provisional Criteria for Global Flares in Childhood-Onset Systemic Lupus ErythematosusHermine I Brunner, Michael Holland, Michael W Beresford, et al.
The Journal of Rheumatology|November 16, 2020
Development and Testing of Reduced Versions of the Manual Muscle Test-8 in Juvenile DermatomyositisSilvia Rosina, Giulia C Varnier, Angela Pistorio, et al.
American Heart Journal|September 1, 2020
RHAPSODY: Rationale for and design of a pivotal Phase 3 trial to assess efficacy and safety of rilonacept, an interleukin-1α and interleukin-1β trap, in patients with recurrent pericarditisAllan L Klein, Massimo Imazio, Antonio Brucato, et al.
European Urology Oncology|June 2, 2021
How to Select the Optimal Candidates for Renal Mass BiopsyAlberto Martini, Alessandro Larcher, Carlo Andrea Bravi, et al.
RMD Open|October 19, 2022
A systematic literature review informing the consensus statement on efficacy and safety of pharmacological treatment with interleukin-6 pathway inhibition with biological DMARDs in immune-mediated inflammatory diseasesKastriot Kastrati, Daniel Aletaha, Gerd R Burmester, et al.
Arthritis Care & Research|May 13, 2017
Effect of Biologic Therapy on Clinical and Laboratory Features of Macrophage Activation Syndrome Associated With Systemic Juvenile Idiopathic ArthritisGrant S Schulert, Francesca Minoia, John Bohnsack, et al.
Pageof 67